临床上分为酒精性肝病（ALD）和非酒精性脂肪性肝病（NAFLD）两大类。
The FLD includes alcohol-induced liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD).
我们展示了人类免疫细胞在体外非酒精性脂肪性肝病，说明酒的确影响天然免疫炎症相关的细菌和病毒的感染。
What we showed in human immune cells in vitro petri dish-type alcohol administration is that alcohol indeed affects inflammation and in turn innate immunity related to bacterial and viral infections.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的：研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
Objetive: To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases (NAFLD).
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制：四步模型，包括肝硬化进展的脂质释放和肝微梗阻的作用。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制：四步模型，包括肝硬化进展的脂质释放和肝微梗阻的作用。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
应用推荐